In Belgium pharmaceutical companies contribute to the financing of the health system through a tax calculated on the basis of sales of reimbursed medicines. On 26 June 2007, the Belgian Government proposed a series of tax reductions and exemptions that would represent an annual budget of around EUR 47 million. At the time of its review, the Commission asked the Belgian authorities to make some adjustments in order to distribute the aid more efficiently. Following these adjustments, the European Commission has decided not to raise any objections and has concluded that the proposed measures are now compatible with the common market.